Medical network on April 6 - leading drug companies listed on the company, slice seed Huang, ma yinglong successively increases, its part of the "trump card" products have drug firms have said prices are "traditional Chinese medicine resource prices and labor costs continue to rise", our reporter found, proprietary Chinese medicine inflationary expectations this year is strong, but still dare to rise more exclusive varieties, from the "benefit" and retail pharmacy. 

 

Increase in the price of listed companies "hot style" sound a proprietary Chinese medicine rise? 

 

Is in the company, wang Huang shortly after the rise in price, another well-known listed companies ma yinglong's exclusive selling proprietary Chinese medicine musk hemorrhoids ointment supply price by 18%, ma yinglong released a public announcement. It is understood that the product leading products for the company, and has entered the medicine and medical insurance directory, its 2015 urban retail pharmacies in China traditional hemorrhoids medicine victory, sales of nearly 250 million yuan; And channels in the hospital the medical field, its name into the first three sales, sales of nearly 140 million yuan. 

 

Similarly, the company after the price of glue mucilage is its "cash cow" -- a has entered into the exclusive proprietary Chinese medicine health insurance directory. 

 

Piece of wang Huang its star products such as compound seed Huang buccal tablet, compound seed Huang ointment and so on, are its exclusive proprietary Chinese medicine, all belong to "hot style" products. 

 

Proprietary Chinese medicine price, flowering including retail pharmacies. "Compound glue mucilage products such as prices, even to a certain extent, make up for the drugstore medical instrument, family planning supplies sales loss to network gap, visible they are more than welcome." A chain pharmacies, head of the guangzhou told our reporter, "hot style" as the market, these products brand marketing, channel development, cultivating consumers are quite mature in place, many "iron powder" seems to be not too sensitive to adjust the price. Pricing "and at the same time, manufacturers tend to make greater efforts to buy a gift and so on preferential so market acceptance is fair." The source said. 

 

Exclusive varieties repeatedly raise is behind its plenty of "hand". "A lot of listed companies through every once in a while, moderately improve market price to ensure that the performance of leading products and profits." An industry observers told our reporter, dare to rise in price of the product has the following basic things in common: retail market well-regarded entrenched, not afraid or few similar products competition, price every time, and so did the earnings up without losing too many consumers. 

 

"Product go hospital channels to meet the tender sharply" bargain ", so if you don't want to sell, major retail market will be more to ensure profits." The observers analysis thinks, although the increase in the price of raw materials and artificial cost are the facts, but behind the proprietary Chinese medicine to raise prices, have their pricing strategies to consider. 

 

Drug prices relatively stable as a whole 

 

It is reported that after three years of "low", the Chinese herbal medicine price rebound began last year. Last year, according to the domestic drug market quotation successively experienced led, rose, and catch up three stages. Notoginseng, evodia rutaecarpa, atractylodes, etc, for example, double years gains have been even more than three times. , market participants said: some Chinese herbal medicine or continue rising trend this year, and may even continue into next year. 

 

Also have pharmacy head told our reporter, at present, drug overall prices remain relatively stable, fluctuation is not big, so consumers feel is not obvious.